PAX5 and Miyoshi myopathy: The downregulation of tumor suppressors PAX5 [15–17] and HOXB3 [23] by CRE mutations in MM is entirely consistent with their decreased expression contributing to development and progression of MM as is the case with other B-cell malignancies.